Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2502782

N#[N+]c1ccc(CN)cc1.[Cl-]

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 1/20 0.48
▸ LOXL2 Q9Y4K0 8/20 0.46
▸ ABAT P80404 1/20 0.44
▸ TAAR1 Q96RJ0 1/20 0.41
▸ ADRB2 P07550 1/20 0.40
▸ CA1 P00915 2/20 0.38
▸ CA2 P00918 2/20 0.38
▸ F10 P00742 1/20 0.38
▸ F11 P03951 1/20 0.38
▸ CA12 O43570 1/20 0.38
▸ CA4 P22748 1/20 0.38
▸ CA6 P23280 1/20 0.38
▸ CA5A P35218 1/20 0.38
▸ CA7 P43166 1/20 0.38
▸ CA9 Q16790 1/20 0.38
▸ CA14 Q9ULX7 1/20 0.38
▸ CA5B Q9Y2D0 1/20 0.38
▸ ST14 Q9Y5Y6 1/20 0.38
▸ MAPT P10636 1/20 0.37
▸ CYP2A6 P11509 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL111287 0.97 HRH3 (0.50) HRH3LOXL2ABATTAAR1ADRB2
SCHEMBL27641801 0.89 LOXL2 (0.44) HRH3LOXL2ABATTAAR1CA1
SCHEMBL23356017 0.89 LOXL2 (0.44) HRH3LOXL2ABATTAAR1CA1
Hydrochloric Acid SCHEMBL9445131 0.79 ALDH1A1 (0.42) —
SCHEMBL1535981 0.78 TAAR1 (0.50) LOXL2TAAR1CA1CA2CA12
Hydrochloric Acid SCHEMBL11205797 0.78 — —
SCHEMBL19416225 0.76 ALDH1A1 (0.44) CA1CA2CA4CA6
Hydrochloric Acid SCHEMBL29232066 0.75 LOXL2 (0.50) HRH3LOXL2ABATTAAR1ADRB2
SCHEMBL15828 0.74 HRH3 (0.79) HRH3LOXL2ABATTAAR1ADRB2
SCHEMBL27238704 0.74 HRH3 (0.79) HRH3LOXL2ABATTAAR1ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3820629-B1 PROCESS FOR FORMING A POLYMERIC ORGANIC FILM AT THE SURFACE OF A METAL SUBSTRATE USING A GEL COMMISSARIAT ENERGIE ATOMIQUE (FR) 2024-11-27 — — EP claimed
EP-3077127-B1 ADHESION PRIMER FOR PAINT COMMISSARIAT ENERGIE ATOMIQUE (FR) 2018-11-14 — — EP claimed
US-20250281681-A1 NEW DEVICES FOR USE FOR TREATING CEREBRAL ANEURYSMS INST NAT SANTE RECH MED (FR) 2025-09-11 — — US disclosed
EP-4333922-B1 NEW DEVICES FOR USE FOR TREATING CEREBRAL ANEURYSMS INST NAT SANTE RECH MED (FR) 2025-09-03 — — EP disclosed
EP-3820629-B1 PROCESS FOR FORMING A POLYMERIC ORGANIC FILM AT THE SURFACE OF A METAL SUBSTRATE USING A GEL COMMISSARIAT ENERGIE ATOMIQUE (FR) 2024-11-27 — — EP disclosed
EP-3891229-B1 PROCESS FOR PREPARING A SURFACE WITH BACTERIOSTATIC ACTIVITY AND SURFACE THUS PREPARED COMMISSARIAT ENERGIE ATOMIQUE (FR) 2024-03-27 — — EP disclosed
EP-4333922-A1 NEW DEVICES FOR USE FOR TREATING CEREBRAL ANEURYSMS Institut national de la santé et de la recherche médicale (INSERM) (FR) 2024-03-13 — — EP disclosed
WO-2022233944-A9 NEW DEVICES FOR USE FOR TREATING CEREBRAL ANEURYSMS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2022-12-15 — — WO disclosed
WO-2022233944-A1 NEW DEVICES FOR USE FOR TREATING CEREBRAL ANEURYSMS INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) (FR) 2022-11-10 — — WO disclosed
US-20220073758-A1 PROCESS FOR PREPARING A SURFACE WITH BACTERIOSTATIC ACTIVITY AND SURFACE THUS PREPARED Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2022-03-10 — — US disclosed
EP-3891229-A1 PROCESS FOR PREPARING A SURFACE WITH BACTERIOSTATIC ACTIVITY AND SURFACE THUS PREPARED Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2021-10-13 — — EP disclosed
US-20140044884-A1 PROCESS FOR PREPARING AN ORGANIC FILM AT THE SURFACE OF A SOLID SUPPORT BY TRANSFER OR BY SPRAYING COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2014-02-13 — — US disclosed
US-20140001048-A1 COATING METHOD BY ELECTROCATALYZED CHEMICAL GRAFTING OF A SURFACE OF A SUBSTRATE WITH A POLYMERIC LAYER PEGASTECH (FR) 2014-01-02 — — US disclosed
US-20130081953-A1 METHOD FOR TREATING THE SURFACE OF A DEVICE FOR DISPENSING A FLUID PRODUCT VALOIS SAS (FR) 2013-04-04 — — US disclosed
US-20130022750-A1 METHOD FOR TREATING THE SURFACE OF A DEVICE FOR DISPENSING A FLUID PRODUCT VALOIS SAS (FR) 2013-01-24 — — US disclosed
US-20130005913-A1 METHOD FOR TREATING THE ELASTOMER SURFACE OF A DEVICE FOR DISPENSING A FLUID PRODUCT VALOIS SAS (FR) 2013-01-03 — — US disclosed
US-20120318677-A1 METHOD FOR TREATING THE SURFACE OF A DEVICE FOR DISPENSING A FLUID PRODUCT VALOIS SAS (FR) 2012-12-20 — — US disclosed
US-20120312688-A1 CATION EXCHANGE MEMBRANE HAVING ENHANCED SELECTIVITY, METHOD FOR PREPARING SAME AND USES THEREOF COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2012-12-13 — — US disclosed
US-20110244585-A1 CHEMICAL SENSORS CONTAINING CARBON NANOTUBES, METHOD FOR MAKING SAME, AND USES THEROF COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2011-10-06 — — US disclosed
US-20100323119-A1 PROCESS FOR THE PREPARATION OF AN ORGANIC FILM AT THE SURFACE OF A SOLID SUPPORT WITH OXIDIZING TREATMENT COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2010-12-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220073758-A1 PROCESS FOR PREPARING A SURFACE WITH BACTERIOSTATIC ACTIVITY AND SURFACE THUS PREPARED DRD1, DRD2, DRD4 HRH3 92/4885LOXL2 3631/4885ABAT 4001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback